A Phase I Study of L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) in Combination With the CALGB Regimen During Induction and Consolidation Phases in the Treatment of Adult Patients With Acute Lymphoblastic Leukemia and Lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 18 Apr 2017
At a glance
- Drugs ERY-ASP (Primary) ; Antineoplastics
- Indications Acute lymphoblastic leukaemia
- Focus Adverse reactions
- Sponsors ERYtech Pharma
- 10 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.
- 13 Feb 2017 Planned number of patients changed from 12 to 24.
- 13 Feb 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2017.